EC

EcoR1 Capital Portfolio holdings

AUM $2.34B
1-Year Est. Return 204.53%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+204.53%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$2.19B
AUM Growth
+$107M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
39
New
Increased
Reduced
Closed

Top Buys

1
+$65M
2
+$31.9M
3
+$26M
4
PCVX icon
Vaxcyte
PCVX
+$20.1M
5
MREO
Mereo BioPharma
MREO
+$15M

Top Sells

1
+$233M
2
+$89.3M
3
+$78M
4
XNCR icon
Xencor
XNCR
+$43.2M
5
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$34.4M

Sector Composition

1 Healthcare 99.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MREO
26
Mereo BioPharma
MREO
$54.9M
$3.27M 0.15%
+7,856,466
CAMP icon
27
CAMP4 Therapeutics
CAMP
$228M
$1.99M 0.09%
+325,000
SRZNW icon
28
Surrozen Inc Warrant
SRZNW
$51.4K
$100K ﹤0.01%
4,444
-62,221
PEPG icon
29
PepGen
PEPG
$104M
– –
-800,000
MDGL icon
30
Madrigal Pharmaceuticals
MDGL
$11.5B
– –
-75,000
KURA icon
31
Kura Oncology
KURA
$905M
– –
-872,500
ALKS icon
32
Alkermes
ALKS
$7.03B
– –
-500,000
PRME icon
33
Prime Medicine
PRME
$641M
– –
-1,543,326
QURE icon
34
uniQure
QURE
$1.8B
– –
-3,988,971
RNAM
35
DELISTED
Avidity Biosciences
RNAM
– –
-765,000
TNGX icon
36
Tango Therapeutics
TNGX
$3.18B
– –
-10,630,736
MTSR
37
DELISTED
Metsera Inc
MTSR
– –
-271,529
CMPS
38
Compass Pathways
CMPS
$1.76B
– –
-265,137
APLS
39
DELISTED
Apellis Pharmaceuticals
APLS
– –
-3,447,156
1
2